Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion type Assertion NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_head.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion evidence source_evidence_literature NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion SIO_000772 15598955 NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion wasDerivedFrom befree-2016 NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.
- NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_assertion wasGeneratedBy ECO_0000203 NP472744.RAVwlF20-5k-UytTxzNbnh65JLR0f_zsy4MtrIo7D6CZg130_provenance.